Evidence map›Paper›PMID 22718307›Full record

ArticleBreast cancer research and treatment2012

The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy.

T May Pini, Sarah T Hawley, Yun Li, Steven J Katz, Jennifer J Griggs

Abstract read
In one paragraph

Article in Breast cancer research and treatment, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

T May PiniDepartment of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard Unit 1360, Houston, TX 77030, USA. tmpini@mdanderson.org
Sarah T Hawley
Yun Li
Steven J Katz
Jennifer J Griggs
University of Michigan–Ann Arbor · USMichigan Medicine · USThe University of Texas MD Anderson Cancer Center · US

Funding

CALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAMU58DP000807 · DP · PUBLIC HEALTH INSTITUTE · PI SNIPES, KURT P · 2007 to 2011
$22.5M
Surgical Treament for Early State Breast CancerR01CA088370 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KATZ, STEVEN J. · 2001 to 2009
$4.3M
Racial/Ethnic Disparities In Work and Qol Outcomes In Survivors of Breast CancerR01CA109696 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAWLEY, SARAH T, KATZ, STEVEN J. · 2004 to 2010
$3.0M
Racial/Ethnic and SES Disparities in Quality of Breast Cancer Systemic TherapyR01CA139014 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GRIGGS, JENNIFER J, KATZ, STEVEN J. · 2009 to 2013
$2.4M
Quality of Cancer Care Evaluation and InterventionsK05CA111340 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KATZ, STEVEN J. · 2006 to 2011
$625k
NCCDPHP CDC HHS 1U58DP00807-01NCI NIH HHS K05CA111340NCI NIH HHS K05CA111340-01A1NCI NIH HHS N01-PC-35139NCI NIH HHS N01-PC-35145NCI NIH HHS N01-PC-54404NCI NIH HHS R01 CA088370NCI NIH HHS R01 CA109696NCI NIH HHS R01 CA139014
6 · The paper itself

Abstract

The extent to which medical oncologists consider non-clinical patient factors when deciding to recommend adjuvant chemotherapy is unknown. Medical oncologists who treated a population-based sample of early stage breast cancer patients reported to the Los Angeles and Detroit Surveillance, Epidemiology, and End Results registries 2005-2007 were asked how strongly they consider a patient's ability to follow instructions, level of social support, and level of work support/flexibility in decisions to recommend adjuvant chemotherapy. Responses of 4 (Quite strongly) or 5 (Very strongly) on a five-point Likert scale defined strong consideration. Associations between oncologist/practice characteristics and strong consideration of each non-clinical factor were examined. 134 oncologists (66 %) reported strong consideration of one or more factor. Ability to follow instructions was strongly considered by 120 oncologists (59 %), social support by 78 (38 %), and work support/flexibility by 73 (36 %). Larger percent of practice devoted to breast cancer was associated with lower likelihood of strongly considering ability to follow instructions [odds ratio (OR) 0.98, 95 % confidence interval (CI) 0.97-0.99; P = 0.04]. Increased years in practice was associated with lower likelihood of strongly considering social support (OR 0.96, CI 0.93-0.99; P = 0.011), while non-white race (OR 2.1, CI 1.03-4.26; P = 0.041) and tumor board access (OR 2.04, CI 1.01-4.12; P = 0.048) were associated with higher likelihood. Non-white race was associated with strongly considering work support/flexibility (OR 2.44, CI 1.21-4.92; P = 0.013). Tumor board access (OR 2, CI 1.00-4.02; P = 0.051) was borderline significant. Non-clinical patient factors play a role in medical oncologist decision-making for breast cancer adjuvant chemotherapy recommendations.

Indexed as

Decision MakingPatient SelectionBreast NeoplasmsChemotherapy, AdjuvantFemaleHealth Care SurveysHumansLogistic ModelsLos AngelesMaleMedical OncologyMichiganMultivariate AnalysisPractice Patterns, Physicians'SEER ProgramSocial Support

Identifiers

PMID22718307
PMCPMC5513505
OpenAlexW2050730506

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.